SMSPHARMA SMS Pharmaceuticals Ltd Other Situations Announcement 2025 - Monitoring Report SMS Pharmaceuticals Ltd reported on the Monitoring Agency's assessment of the use of funds from their preferential issue of convertible warrants, totaling Rs. 114.30 crore, for the quarter ending March 31, 2025..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for SMS Pharmaceuticals Ltd